Can a common anti-inflammatory cut opioid use after spinal fusion?
NCT ID NCT06513208
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the anti-inflammatory drug ketorolac can lower the amount of strong painkillers (opioids) needed after lumbar spinal fusion surgery. About 140 adults having one- or two-level fusion will receive either ketorolac or a placebo for the first 48 hours after surgery. The goal is to see if ketorolac helps control pain without harming bone healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUMBAR SPINAL FUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Maryland St. Joseph Medical Center
RECRUITINGTowson, Maryland, 21204, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common hand condition reveal hidden heart disease? new imaging trial investigates
- Belly fat vs. body mass index: which better predicts spine surgery risks?
- Simple tube after spine surgery may cut complications
- New nerve block technique aims to cut opioid use after back surgery
- Less invasive back surgery may be as effective as major revision for spinal stenosis
- Spine surgeons test new CT technique to catch hidden instability during surgery